(Stroke. 2000;31:1974.)
© 2000 American Heart Association, Inc.
Original Contributions |
, MDFrom the Department of Neurology, Faculty of Medicine, and Institute of Neurological Sciences and Psychiatry, Hacettepe University, Ankara, Turkey.
Correspondence to Turgay Dalkara, Department of Neurology, Hacettepe University Hospitals, Ankara, 06100, Turkey. E-mail dalkara{at}tr-net.net.tr
Background and PurposeReperfusion injury is one of the factors that unfavorably affects stroke outcome and shortens the window of opportunity for thrombolysis. Surges of nitric oxide (NO) and superoxide generation on reperfusion have been demonstrated. Concomitant generation of these radicals can lead to formation of the strong oxidant peroxynitrite during reperfusion.
MethodsWe have examined the role of NO generation and peroxynitrite formation on reperfusion injury in a mouse model of middle cerebral artery occlusion (2 hours) and reperfusion (22 hours). The infarct volume was assessed by 2,3,5-triphenyl tetrazolium chloride staining; blood-brain barrier permeability was evaluated by Evans blue extravasation. Nitrotyrosine formation and matrix metalloproteinase-9 expression were detected by immunohistochemistry.
ResultsInfarct volume was significantly decreased (47%) in
animals treated with the nonselective nitric oxide synthase (NOS)
inhibitor N
-nitro-L-arginine
(L-NA) at reperfusion. The specific inhibitor of neuronal
NOS, 7-nitroindazole (7-NI), given at reperfusion, showed no
protection, although preischemic treatment with 7-NI
decreased infarct volume by 40%. Interestingly, prereperfusion
administration of both NOS inhibitors decreased tyrosine
nitration (a marker of peroxynitrite toxicity) in the ischemic
area. L-NA treatment also significantly reduced vascular damage, as
indicated by decreased Evans blue extravasation and matrix
metalloproteinase-9 expression.
ConclusionsThese data support the hypothesis that in addition to the detrimental action of NO formed by neuronal NOS during ischemia, NO generation at reperfusion plays a significant role in reperfusion injury, possibly through peroxynitrite formation. Contrary to L-NA, failure of 7-NI to protect against reperfusion injury suggests that the source of NO is the cerebrovascular compartment.
Department of Anesthesiology University of Alabama at Birmingham
This article has been cited by other articles:
![]() |
H. Karatas, Y. Aktas, Y. Gursoy-Ozdemir, E. Bodur, M. Yemisci, S. Caban, A. Vural, O. Pinarbasli, Y. Capan, E. Fernandez-Megia, et al. A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood-Brain Barrier and Provides Neuroprotection J. Neurosci., November 4, 2009; 29(44): 13761 - 13769. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Reddy and V. Labhasetwar Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury FASEB J, May 1, 2009; 23(5): 1384 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Narasimhan, J. Liu, Y. S. Song, J. L. Massengale, and P. H. Chan VEGF Stimulates the ERK 1/2 Signaling Pathway and Apoptosis in Cerebral Endothelial Cells After Ischemic Conditions Stroke, April 1, 2009; 40(4): 1467 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. T. Hare, A. K. Y. Tsui, A. T. McLaren, T. E. Ragoonanan, J. Yu, and C. D. Mazer Anemia and Cerebral Outcomes: Many Questions, Fewer Answers Anesth. Analg., October 1, 2008; 107(4): 1356 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, B. Jin, L. Li, E. R. Block, and J. M. Patel Nitric oxide-induced persistent inhibition and nitrosylation of active site cysteine residues of mitochondrial cytochrome-c oxidase in lung endothelial cells Am J Physiol Cell Physiol, April 1, 2005; 288(4): C840 - C849. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Muyderman, M. Nilsson, and N. R. Sims Highly Selective and Prolonged Depletion of Mitochondrial Glutathione in Astrocytes Markedly Increases Sensitivity to Peroxynitrite J. Neurosci., September 15, 2004; 24(37): 8019 - 8028. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Unal-Cevik, M. Kilinc, A. Can, Y. Gursoy-Ozdemir, and T. Dalkara Apoptotic and Necrotic Death Mechanisms Are Concomitantly Activated in the Same Cell After Cerebral Ischemia Stroke, September 1, 2004; 35(9): 2189 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Fagan, D. C. Hess, E. J. Hohnadel, D. M. Pollock, and A. Ergul Targets for Vascular Protection After Acute Ischemic Stroke Stroke, September 1, 2004; 35(9): 2220 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Iwashita, N. Tojo, S. Matsuura, S. Yamazaki, K. Kamijo, J. Ishida, H. Yamamoto, K. Hattori, N. Matsuoka, and S. Mutoh A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 425 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gursoy-Ozdemir, A. Can, and T. Dalkara Reperfusion-Induced Oxidative/Nitrative Injury to Neurovascular Unit After Focal Cerebral Ischemia Stroke, June 1, 2004; 35(6): 1449 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Maier, L. Hsieh, F. Yu, P. Bracci, and P. H. Chan Matrix Metalloproteinase-9 and Myeloperoxidase Expression: Quantitative Analysis by Antigen Immunohistochemistry in a Model of Transient Focal Cerebral Ischemia Stroke, May 1, 2004; 35(5): 1169 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ding-Zhou, C. Marchand-Verrecchia, B. Palmier, N. Croci, P.-E. Chabrier, M. Plotkine, and I. Margaill Neuroprotective Effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an Inhibitor of Neuronal Nitric-Oxide Synthase and an Antioxidant, in Model of Transient Focal Cerebral Ischemia in Mice J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Coert, R. E. Anderson, and F. B. Meyer Is neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH? Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H151 - H159. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Peeters-Scholte, J. Koster, W. Veldhuis, E. van den Tweel, C. Zhu, N. Kops, K. Blomgren, D. Bar, S. van Buul-Offers, H. Hagberg, et al. Neuroprotection by Selective Nitric Oxide Synthase Inhibition at 24 Hours After Perinatal Hypoxia-Ischemia Stroke, September 1, 2002; 33(9): 2304 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Han, Y. Qiao, M. Karabiyikoglu, R. G. Giffard, and M. A. Yenari Influence of Mild Hypothermia on Inducible Nitric Oxide Synthase Expression and Reactive Nitrogen Production in Experimental Stroke and Inflammation J. Neurosci., May 15, 2002; 22(10): 3921 - 3928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ozaki, S. Kawashima, T. Hirase, T. Yamashita, M. Namiki, N. Inoue, K.-i. Hirata, and M. Yokoyama Overexpression of Endothelial Nitric Oxide Synthase in Endothelial Cells Is Protective against Ischemia-Reperfusion Injury in Mouse Skeletal Muscle Am. J. Pathol., April 1, 2002; 160(4): 1335 - 1344. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |